Plastomet 50 Injection
Marketer
Khandelwal Laboratories Pvt Ltd
Salt Composition
Methotrexate (50mg)
Overview Plastomet 50 Injection
Oncoject 50 Injection is a cancer treatment administered intravenously for various cancers including breast, head and neck, lung, hematologic, bone, lymphatic, and uterine cancers. It's often part of a combined therapeutic regimen. Administered solely under a physician's direct supervision, self-medication is strictly prohibited. Dosage and frequency are determined individually by your oncologist based on your specific condition and may vary over time; adhere precisely to the prescribed regimen. Incorrect usage or overdose can lead to severe adverse reactions. While benefits may not be immediately apparent (weeks or months), discontinue use only under your doctor's instruction. Alcohol consumption should be avoided due to potential liver damage. Common side effects include nausea, vomiting, anorexia, abdominal discomfort, fatigue, mucositis, and leukopenia. Folic acid supplementation may mitigate some of these. Report persistent or worsening side effects immediately. Severe adverse events are possible; this is a potent medication. Oncoject 50 can compromise immune function and potentially impact blood, liver, or kidney health; regular blood tests will be required for monitoring. Prior to treatment, disclose any pre-existing gastrointestinal, hepatic, or renal issues, and all current medications, especially those for infections. Numerous drug interactions are possible; ensure your healthcare team has a complete medication list. This medication is contraindicated during pregnancy and lactation due to fetal harm risk. Pregnancy prevention is advised for both partners for several months post-treatment. Pre- and ongoing treatment includes bloodwork, imaging (e.g., X-rays), and physical assessments as determined by your doctor.
Uses of Plastomet 50 Injection
Cancer Therapy
Major Benefits of Plastomet 50 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Plastomet 50 Injection:
- Abdominal pain
- Indigestion
- Loss of appetite
- Nausea
- Vomiting
- Tiredness
- Mouth sore
- Decreased white blood cell count
How to use Plastomet 50 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Plastomet 50 Injection works:
Plastomet 50 Injection is a chemotherapeutic agent that inhibits dihydrofolate reductase, a crucial enzyme for DNA replication within cancerous cells. This inhibition curtails cancer cell proliferation, ultimately leading to their demise.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Plastomet 50 Injection and alcohol. Physician consultation is recommended.
PregnancyUNSAFE
Administering Plastomet 50 Injection during pregnancy presents a substantial risk. Pregnant individuals should consult their physician; research in animal and human studies indicates considerable harm to the fetus.
Breast feedingUNSAFE
Administering Plastomet 50 Injection while breastfeeding poses a safety risk. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
The administration of Plastomet 50 Injection can potentially reduce alertness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCAUTION
Patients with impaired kidney function should use Plastomet 50 Injection cautiously, potentially requiring a modified dosage. Physician consultation is recommended. Close monitoring of renal function is advised during treatment.
LiverCAUTION
Individuals with liver impairment should use Plastomet 50 Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Plastomet 50 Injection is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Plastomet 50 Injection :
Omit a Plastomet 50 Injection dose? Seek your physician's advice.
Facts to Know About Plastomet 50 Injection
| Label | Value |
|---|---|
| Chemical Type | Glutamate Derivative |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Actions | Methotrexate: An Antimetabolite |
3,018 People bought this recently